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Background & purpose: Skeletal stem cells (SSCs) and impaction bone grafting (IBG) can be
combined to produce a mechanically stable living bone composite. This novel strategy has
been translated to the treatment of avascular necrosis of the femoral head. Surgical
technique, clinical follow-up and retrieval analysis data of this translational case series is
presented.
Methods: SSCs and milled allograft were impacted into necrotic bone in five femoral heads
of four patients. Cell viability was confirmed by parallel in vitro culture of the cell-graft
constructs. Patient follow-up was by serial clinical and radiological examination. Tissue
engineered bone was retrieved from two retrieved femoral heads and was analysed by
histology, microcomputed tomography (mCT) and mechanical testing.
Results: Three patients remain asymptomatic at 22- to 44-month follow-up. One patient
(both hips) required total hip replacement due to widespread residual necrosis. Retrieved
tissue engineered bone demonstrated a mature trabecular micro-architecture histologi-
cally and on mCT. Bone density and axial compression strength were comparable to
trabecular bone.
Conclusions: Clinical follow-up shows this to be an effective new treatment for focal early
stage avascular necrosis of the femoral head. Unique retrieval analysis of clinically
translated tissue engineered bone has demonstrated regeneration of tissue that is both
structurally and functionally analogous to normal trabecular bone.
ª 2013 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and
Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.Introduction or sickle cell disease, whilst the chance of developing AVN afterAVN of the femoral head is a disease that usually affects young
adults, progressing to bone collapse and osteoarthritis in over
80% of untreated patients.1 Progression occurs even in 59% of
asymptomatic patients.2 Most cases are idiopathic but it is
commonlyattributed to steroid therapy, chemotherapy, alcohol768.
uk (A. Aarvold).
College of Surgeons of Ed
td. All rights reserved.traumatic hip dislocation may be as high as 40%.3 Position and
distribution of the necrotic bone in the femoral head have a
bearing on prognosis2,4 however the most important predictor
remains progression from an intact bony architecture (Ficat &
Arlet Stage I or II) to loss of normal bone structure and
involvement of articular cartilage (Ficat & Arlet Stage III or IV).5inburgh (Scottish charity number SC005317) and Royal College of
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tomatic stages, have a high probability of requiring a total hip
replacement (THR). Joint preserving therapies are therefore
advocated by most authorities to prevent the progression to
collapse. These include core decompression,1 electrical stim-
ulation,6 tantalum trabecular metal rods,7 vascularised fibular
grafts,8 fibular or tibial strut grafts,9 concentrated autologous
bone marrow10 or hydroxyapatite rods coated with skeletal
stem cells.11
Skeletal stem cells (SSCs) have been used for the treatment
of avascular necrosis of the femoral head,12 though this
treatment does not provide any structural support for the
overlying cartilage. Impaction bone grafting (IBG) can provide
mechanical support and has been used as a void-filler in
revision hip surgery for over forty years13 and in the treatment
of AVN.14Whilst some remodelling has been demonstrated on
histological specimens from IBG in acetabula and femora,
areas of non-incorporated graft with associated necrosis,
fibrocartilage and fibrosis remain in all specimens.15e17
SSCs can be combined with IBG to improve both the me-
chanical and biological characteristics of the graft.18 This
novel technique has been translated from the laboratory to
the clinic for the treatment of early stage AVN. We report our
case series from this novel tissue engineering strategy. Two
femoral heads, both in the same patient, have collapsed
requiring THR. This has however provided the opportunity for
retrieval of the human tissue engineered bone and for unique
ex vivo analysis.Materials and methods
Surgical technique
Milled allograft was prepared from fresh frozen femoral heads
according to standard clinical practice. The patient was posi-
tioned laterally on the operating table and bone marrow was
aspirated from the posterior iliac crest, rotating and re-angling
the needle regularly to minimise contamination with venous
blood. The marrow was concentrated in theatre by calibrated
centrifugation (Marrowstim, Biomet, Swindon, UK) to isolate
the nucleated cell fraction. This provided a concentrated pool
of pleuripotent SSCs,18 which was mixed with the prepared
allograft. The patient was then placed supine on the operating
table to allow fluoroscopic guidance of instrumentation up the
femoral neck into the necrotic area of the femoral head.Table 1 e Patient details.
Patient Age Attributed cause
1 42 Systemic steroids for sub-arachnoid
haemorrhage
2 40 Alcohol
3 31 Idiopathic
4 32 Systemic steroids for testicular carcinoma
a ¼ Ficat & Arlet Classification is used throughout this study unless otheThrough a 2 cm incision in the lateral thigh, a channel was
drilled over a guidewire into the sub-chondral bone and the
necrotic bone was removed by curettage. Cell-seeded milled
allograft was impacted retrograde into the channel using a
12 mm diameter Xchange tube saw (Stryker, Newbury, UK).
Samples of allograft/SSCmix were retained for parallel in vitro
analysis of cell viability. Patientsmaintained protectedweight
bearing for 6 weeks post-operatively and follow-up was by
serial radiological and clinical examination.Patient cohort
Four patients, all with bilateral AVN, were treated at our
institution using this tissue engineering strategy. Three of the
patients presented with advanced disease in one hip,
requiring contra-lateral THR (Table 1).Parallel in vitro assessment
The retained samples were cultured in basal media for 14, 28
and 42 days, with twice weekly media changes, prior to
staining with CellTracker Green and ethidium homodimer
(CTG-EH). Microscope images were recorded using Carl Zeiss
Axiovision software Ver 3.0 via an AxioCamHR digital camera
on an Axiovert 200 inverted microscope (Carl Zeiss Ltd, Wel-
wyn Garden City, UK) under fluorescent light.Retrieval of specimens
In Patient 4, both femoral heads progressed to collapse
requiring bilateral THR, on the right after 13 months and on
the left after 19 months. The femoral heads were retrieved,
with patient consent and prior ethical approval (LREC194/99/
1), photographed and fixed in 4% paraformaldehyde (PFA)
prior to further analysis.Microcomputed tomography (mCT)
The retrieved femoral heads were scanned using an Xtek
Benchtop 160Xi scanner (Xtek Systems Ltd, Tring, UK) equip-
ped with a Hamamatsu C7943 X-ray flat panel sensor
(Hamamatsu Photonics, Welwyn Garden City, UK). Scan res-
olutionwas up to 31-mm, at 150 kV, 60 mA using amolybdenum
target with an exposure time of 534 ms and 4 digital gain.
Reconstructed volume images were analysed using VGStudioRight hip
stagea
Right hip
treatment
Left hip
stagea
Left hip
treatment
IV THR II SSC/IBG
III THR II SSC/IBG
III THR II SSC/IBG
II SSC/IBG II SSC/IBG
rwise stated.
Fig. 1 e Schematic identifying the sections processed for
histology.
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Germany).
Histology
For histological analysis of normal trabecular and impacted
bone, representative sections were excised from the femoral
neck, avoiding areas of collapse (Fig. 1, Sections ‘2’ and ‘3’
respectively). Sections of the collapsed necrotic tissue, were
excised and processed in an identical fashion (Fig. 1, Section
‘1’). Cortical bone was not included. Specimens were decal-
cificied in 0.1 M TRIS/5% EDTA solution at pH 7.3 and decal-
cification verified by Faxitron MX-20 micro X-ray (Faxitron
X-ray, Wheeling, IL, USA). After wax embedding, mounting,
processing through graded ethanols and sectioning to 7 mm
thickness, slides were stained with Alcian Blue/Sirius Red
(A/S) and tartrate-resistant acid phosphatase (TRAP). Micro-
scope images were recorded under white and polarised light
on an Axiovert 200 inverted microscope (Carl Zeiss Ltd, Wel-
wyn Garden City, UK).
Mechanical testing
Sections of trabecular, cortical and impacted bone were
excised from each specimen for comparison of mechanical
strength. As described above, these sections were taken from
the femoral neck region to avoid incorporating residualFig. 2 e CTG-EH stain demonstrating enduring cell viability and
weeks culture. b: 4 weeks culture. c: 6 weeks culture, with bridpathology. There was sufficient tissue to harvest two repre-
sentative sections of each tissue type from each femoral head,
providing four samples of each. Cuboidal bone sections
(6.0  7.0  4.0 mm) were prepared using a low-speed dia-
mond-tipped wafering blade (Buehler, Coventry, UK), cali-
brated to 0.1 mm accuracy using electronic callipers (Jade
Products, Rugby, UK) and tested to failure by compression
with a hydraulic actuator (Instron Ltd, High Wycombe, UK). A
compressive force was applied at a constant rate of 4.8 mm
over 60 s (0.08 mm/s), from which stressestrain graphs were
plotted and mechanical strength calculated. In order to
represent the forces sustained in vivo, the direction of force
applied was always in the orientation of the trabecular stress
lines of the femoral neck. Statistical significance was exam-
ined by One-way ANOVA.Results
Clinical follow-up
Three patients remain asymptomatic at 22- to 44-month
follow-up, with no radiological evidence of collapse. One pa-
tient progressed to bilateral collapse requiring THR. This has
afforded the unique opportunity to retrieve tissue engineered
bone from a human case for ex vivo analysis.
Reasons for collapse of femoral heads of Patient 4
At diagnosis, the necrotic area in the right hipwaswidespread
across the sub-chondral bone. MRI analysis confirmed a high
Mitchell score4 suggestive of more widespread necrosis than
was initially suspected, and predictive of increased technical
difficulty in effective curettage of thewhole area. Such disease
may therefore not have been conducive to treatment by such a
percutaneous technique. For the left hip, despitemaintenance
of femoral head architecture on pre-operative radiographs,
high signal could be identified onMRI. Diagnosis on CT scan of
a cyst confirmed degenerative change that may be unsal-
vageable. Collapse in both femoral heads occurred away from
and lateral to the impacted channel of bone,most likely due to
residual necrotic bone.
Parallel in vitro assessment
In vitro culture of SSCs on allograft demonstrated enduring cell
viability and proliferation of the impacted cells, evidenced by
CTG-EH stain (Fig. 2aec).proliferation on in vitro cell-seeded milled allograft. a: 2
ging of SSCs cross the construct. Scale bars [ 200 mm.
Fig. 3 e a: Photograph of the base of right femoral head of Patient 4 following surgical neck cut, showing a clearly
demarcated dense central channel of remodelled impacted bone. b: 3D reconstructed mCT image at 70-m resolution of
retrieved right femoral head. c: Coronal section showing a dense channel of impacted bone up to the necrotic collapsed area.
d: False-colour density analysis within right femoral head; Yellow<1400 Grey Scale units; Red [ 1400e1800 units; Blue
>1800 units. e: 3D reconstructed mCT image at 31-m resolution of the central channel of impacted bone from the left femoral
head. Continuous trabecular architecture is evident throughout the channel. f: Graph of density analysis, corresponding to
Fig. 5, with peaks of trabecular, impacted and cortical bone seen at 1200, 1400 and 1800 units respectively, indicated by
dashed lines.
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Review of the cut surface of each femoral neck identified a
demarcated dense central channel of bone, which continued
through the femoral head and up to the collapsed sub-
chondral bone (Fig. 3a).
Microcomputed tomography (mCT)
Analysis by mCT revealed a dense central channel with a
mature uniform trabecular structure visualised in cross-sec-
tion along its length (Fig. 3b and c). With the exception of
collapsed necrotic sub-chondral tissue, the trabecular micro-
architecture was maintained, and observed to be in continu-
ity throughout the impacted channel of bone (Fig. 3e).
The apparent bone density for trabecular, cortical and
impacted bone was determined by Grey Scale on mCT images.
As expected, bone densities in the right and left femoral heads
were comparable to each other. Cortical bonewas denser than
trabecular bone, with a Grey Scale density of 1800 versus 1200
units. The density of the right and left impacted channels of
bone were also comparable to each other, and greater than
trabecular bone, with a Grey Scale density of 1400 units,
illustrated by false-colour coding (Fig. 3d) and graphically
(Fig. 3f).Fig. 4 e Histology; A/S stain of impacted bone revealed a trabec
lacunae (a), comparable to trabecular bone (b); Parallel birefringe
impacted and trabecular bone (d,e); The necrotic tissue demons
bone (c), with negligible evidence of organisation when viewed
normal osteoclasts and Howship’s lacunae in impacted bone (g
osteoclasts could be observed in the necrotic bone (j). Scale barHistology
A/S staining of tissue from the impacted channels of retrieved
femoral bone showed histology consistent with normal
trabecular bone. Osteocytes within lacunae were visible, sur-
rounded by a lamellar structure (Fig. 4a) which was confirmed
as mature organised bone under polarised light (Fig. 4d). The
micro-architecture of the impacted bone was observed to be
histologically identical to the patient’s normal trabecular bone
(Fig. 4b and e). Low power images of impacted bone confirmed
the presence of a trabecular structure incorporating marrow
(Fig. 4a, inset), thoughmacroscopically and on mCT trabeculae
were more densely arranged (Fig. 3aed). TRAP stain revealed
osteoclasts and Howship’s lacunae on the surfaces of
impacted bone (Fig. 4g) and normal trabecular bone (Fig. 4h).
This microscopic arrangement was grossly different from
tissue in the necrotic area which showed a high concentration
of osteoclasts, eroded bone (Fig. 4j), and a disordered mixture
of cartilage, fibrous tissue and bone (Fig. 4c). There was
negligible evidence of organisation on birefringence (Fig. 4f).
Mechanical testing
Comparable values in compressive strength of the cortical,
trabecular and impacted bone were found between right andular structure (a, inset), with lamellae and cells within
nce confirmed a mature ordered lamellar structure of both
trated a disordered mixture of cartilage, fibrous tissue and
under polarised light (f); TRAP staining demonstrated
) and trabecular bone (h) however a high number of
s: aee [ 100 mm; a inset, c,f [ 200 mm; g,h,j [ 50 mm.
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statistical difference between the compressive strength of
trabecular and cortical bone, which was confirmed on Bon-
ferroni Multiple Analysis (n ¼ 4, p < 0.05). Critically, there was
no statistical difference in the strengths of trabecular and
impacted bone ( p > 0.05).Discussion
This paper describes a techniquewhich appears to be effective
for the treatment of AVN of the femoral head and, critically, is
simple, quick and inexpensive. It supplements each of the
current therapies of core decompression,1 SSCs12 and IBG14 by
providing both a biological stimulus for osteogenesis as well
as mechanical support for the sub-chondral bone. Three pa-
tients remain asymptomatic at up to 44-month follow-up.
Furthermore, the ex vivo analysis of the two collapsed
femoral heads has demonstrated the regeneration of struc-
turally and functionally normal bone.
The continuous trabecular architecture throughout the
impacted channel of bone observed by mCT (Fig. 3b, c and e)
provides evidence of remodelling of the milled allograft, to
create a mature living bone. With the exception of retained
pathology in the sub-chondral bone, critically, no necrotic/
fibrotic tissue was observed within the impacted channel,
indicating all impacted fragments had been integrated,
resorbed or remodelled.
Histological analysis confirmed the presence of a mature
trabecular bone structure (Fig. 4a, inset). Osteoclasts and
Howship’s lacunae were indicative of normal remodelling
(Fig. 4c) and the lamellar micro-architecture of the impacted
bone, with osteocytes in lacunae, was observed to be histo-
logically identical to normal trabecular bone (Fig. 4a and b).
These results indicate SSCs together with the impacted milled
allograft resulted in the formation of a bone composite that
underwent remodelling. Thismust be contrastedwith previous
histological analysis performed on retrieval specimens of IBGFig. 5 e Bar chart demonstrating compressive strengths
(MPa) of trabecular, impacted and cortical bone of both hips
from Patient 4 (n [ 4). One-way ANOVA demonstrated a
statistical difference between trabecular and cortical bone
( p< 0.0001), but no statistical difference between
trabecular and impacted bone. Error bars denote Standard
Error of Mean, ‘ns’ [ no statistical significance.without supplementation with SSCs, whereby islands of non-
incorporated necrotic graft remained in all specimens.15e17
Compression testing demonstrated that the regenerated
bone was of comparable strength to normal ipsilateral
trabecular bone. An aggregate of milled allograft, as originally
impacted into the patient, would crumble under minimal
loading, yet despite no lateral constraints ex vivo the test
segments of impacted bonemaintained their shape indicating
a significant increase in inter-particulate cohesion of the
milled fragments. mCT scans confirmed that the fragments
were conjoined, which together with the compression testing
accounted for the structural integrity. mCT scans confirmed
that the fragments were conjoined, which together with the
compression testing accounted for the structural integrity.Conclusion
While clinical translation of tissue engineering strategies re-
mains rare, this novel case series and ex vivo analysis has
confirmed the potential of SSC/IBG constructs for the treat-
ment of early stage femoral head AVN. Further clinical trials
are necessary, including comparison to concurrent therapies,
though referral can be made to extensive in vitro and in vivo
work regarding SSC augmentation of bone regeneration on
IBG.18e20 This technique may offer potential for treatment of
the broader spectrum of bone defects.Sources of financial support
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